Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Sayed Mehdi Hamadani"'
2
Abstract A73: Integrating in vitro signaling and drug response data from single cell network profiling (SCNP) to inform on individual's AML biology
Autor: William Tse, Angela Rishel, Urte Gayko, Jino Park, Rachael E. Hawtin, Todd Covey, Jame Abraham, Scot C. Remick, Michael Gulrajani, Sayed Mehdi Hamadani, Aaron Cumpston, Michael Craig
Publikováno v: Molecular Cancer Therapeutics. 10:A73-A73
Background: SCNP is a multiparametric flow cytometry-based assay that allows for simultaneous measurement of multiple signaling nodes (stimulus intracellular signaling molecule) in cell subsets from heterogeneous tissues, such as whole blood or PBMC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::72916ae892f1eee79d77c79c1ac32d77
https://doi.org/10.1158/1535-7163.targ-11-a73
Zobrazit plný text záznamu
3
Response to Induction Chemotherapy with Novel Agents Does Not Predict Outcomes of Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
Autor: Michael Craig, Pamela Bunner, Sonia Leadmon, Sayed Mehdi Hamadani, William Tse, Jame Abraham, Laura F. Gibson, Aaron Cumpston, Scot C. Remick, Salman Osman, Abraham S. Kanate
Publikováno v: Blood. 116:1347-1347
Abstract 1347 Introduction: High dose therapy and autologous hematopoietic cell transplantation (AHCT) is a standard therapy option for at least young ( Methods: The study involves 63 consecutive patients who underwent a planned, single AHCT within 1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d0150198ad94d7a22a4b0bee8eefafd1
https://doi.org/10.1182/blood.v116.21.1347.1347
Zobrazit plný text záznamu
4
Regulation of Acute Graft-Versus-Host Disease by MicroRNA-155
Autor: Nicole Stauffer, Sayed Mehdi Hamadani, Catherine Heaphy, Ramasamy Santhanam, Sukhinder Sandhu, Stefan Costinean, Jerry Nuovo, Danilo Perrotti, Carlo M. Croce, Greg Hadley, Guido Marcucci, Steven M. Devine, Ramiro Garzon
Publikováno v: Blood. 116:245-245
Abstract 245 Acute Graft-versus-host disease (aGVHD) is a frequent and lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT) in which donor T cells destroy HLA mismatched host tissues by secreting soluble inflammatory cytok
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a68e008045e2cace976aa383fb2a33aa
https://doi.org/10.1182/blood.v116.21.245.245
Zobrazit plný text záznamu
5
In Vivo T-Cell Depletion Does Not Improve Rates of Graft-Versus-Host Disease and Transplantation Outcomes In Patients Undergoing Peripheral Blood Hematopoietic Cell Transplant
Autor: Aaron Cumpston, Pamela Bunner, Salman Osman, Jame Abraham, Scot C. Remick, Sayed Mehdi Hamadani, Michael Craig, Gerry Hobbs, Sonia Leadmon, Laura F. Gibson, William Tse, Abraham S. Kanate
Publikováno v: Blood. 116:4536-4536
Abstract 4536 Introduction: Allogeneic hematopoietic cell transplant (AHCT) is a potentially curative modality for various benign and malignant hematological disorders. Despite advances in supportive care, graft-versus-host disease (GVHD) remains the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0463fc0e2a746b7a4e1a7df8b5d42bd
https://doi.org/10.1182/blood.v116.21.4536.4536
Zobrazit plný text záznamu
6
Higher Infused CD34+ Cell Dose Improves Survival In Patients Undergoing In Vivo T-Cell Depleted, but Not T-Cell Replete Peripheral Blood Hematopoietic Cell Transplant
Autor: Sayed Mehdi Hamadani, Laura F. Gibson, Kathy Watkins, Pamela Bunner, Gerry Hobbs, Sonia Leadmon, Scot C. Remick, Aaron Cumpston, Jame Abraham, William Tse, Michael Craig, Abraham S. Kanate, Salman Osman
Publikováno v: Blood. 116:1272-1272
Abstract 1272 Introduction: Allogeneic hematopoietic cell transplant (HCT) remains a potentially curative modality for various hematological disorders. The cellular composition of the infused allograft has important ramifications for transplantation
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf693fadba80e3bfa1c2b91850ce0b5b
https://doi.org/10.1182/blood.v116.21.1272.1272
Zobrazit plný text záznamu
7
Allogeneic Transplantation Following Reduced Intensity Conditioning with Fludarabine and Melphalan In Patients with Advanced Myelofibrosis Is Associated with Unacceptable Rates of Acute Graft-Vs-Host Disease and Non-Relapse Mortality
Autor: Sayed Mehdi Hamadani, Anand Jillella, Kavita Natrajan, Samith Thomas Kochuparambil, Farrukh T. Awan
Publikováno v: Blood. 116:4552-4552
Abstract 4552 Allogeneic hematopoietic stem cell transplant (HSCT) offers a potentially curative option for patients with primary myelofibrosis (PMF). The evidence for the utility of allogeneic HSCT originates from early reports documenting a graft-v
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d63c5d047cf86dc68c85372eb77a2214
https://doi.org/10.1182/blood.v116.21.4552.4552
Zobrazit plný text záznamu
8
Clofarabine In Combination with Cyclophosphamide for Treatment of Relapsed/Refractory Acute Leukemia In Adult Patients
Autor: Bobby Chawla, William Tse, Michael Craig, Aaron Cumpston, Sayed Mehdi Hamadani, Abraham S. Kanate, Salman Osman
Publikováno v: Blood. 116:4367-4367
Abstract 4367 Introduction: Clofarabine is a purine nucleoside analogue which is approved for pediatric patients with relapsed or refractory acute lymphoblastic leukemia. A number of small phase I and II studies have shown activity in adult patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b55b4811f368d814aeaa9da08c57aa4
https://doi.org/10.1182/blood.v116.21.4367.4367
Zobrazit plný text záznamu
9
Impact of Response to Thalidomide, Lenalidomide or Bortezomib Containing Induction Chemotherapy on Outcomes of Multiple Myeloma Patients Undergoing Autologous Transplantation – A Multicenter Analysis
Autor: Farrukh T. Awan, Samith Thomas Kochuparambil, Jame Abraham, Sayed Mehdi Hamadani, Michael Craig, Anand Jillella, Salman Osman, Scot C. Remick
Publikováno v: Blood. 116:1351-1351
Abstract 1351 Introduction: High dose therapy and autologous transplantation (HDT-AT) has shown survival benefit for (at least) young, transplant eligible multiple myeloma (MM) patients. Transplant ineligible patients who achieve complete remission (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::927a4854a0b21e133fc06a2c550ac35f
https://doi.org/10.1182/blood.v116.21.1351.1351
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje